These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19060214)

  • 1. Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo.
    Murata T; Lin MI; Aritake K; Matsumoto S; Narumiya S; Ozaki H; Urade Y; Hori M; Sessa WC
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):20009-14. PubMed ID: 19060214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin D2-DP signaling promotes endothelial barrier function via the cAMP/PKA/Tiam1/Rac1 pathway.
    Kobayashi K; Tsubosaka Y; Hori M; Narumiya S; Ozaki H; Murata T
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):565-71. PubMed ID: 23307871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors.
    Gallant MA; Samadfam R; Hackett JA; Antoniou J; Parent JL; de Brum-Fernandes AJ
    J Bone Miner Res; 2005 Apr; 20(4):672-81. PubMed ID: 15765187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin D2 mediates neuronal protection via the DP1 receptor.
    Liang X; Wu L; Hand T; Andreasson K
    J Neurochem; 2005 Feb; 92(3):477-86. PubMed ID: 15659218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma.
    Murata T; Aritake K; Matsumoto S; Kamauchi S; Nakagawa T; Hori M; Momotani E; Urade Y; Ozaki H
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19802-7. PubMed ID: 22106279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin D2 inhibits collagen secretion from lung fibroblasts by activating the DP receptor.
    Ayabe S; Kida T; Hori M; Ozaki H; Murata T
    J Pharmacol Sci; 2013; 121(4):312-7. PubMed ID: 23538675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic prostaglandin D synthase-derived prostaglandin D
    Tsubosaka Y; Maehara T; Imai D; Nakamura T; Kobayashi K; Nagata N; Fujii W; Murata T
    FASEB J; 2019 Jun; 33(6):6829-6837. PubMed ID: 30811953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
    Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
    Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human prostanoid DP receptor stimulates mucin secretion in LS174T cells.
    Wright DH; Ford-Hutchinson AW; Chadee K; Metters KM
    Br J Pharmacol; 2000 Dec; 131(8):1537-45. PubMed ID: 11139429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of functional prostaglandin D (DP) receptors in human corpus cavernosum smooth muscle.
    Moreland RB; Nehra A; Kim NN; Min KS; Albadawi H; Watkins MT; Goldstein I; Traish AM
    Int J Impot Res; 2002 Dec; 14(6):446-52. PubMed ID: 12494276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin D2 suppresses human NK cell function via signaling through D prostanoid receptor.
    Chen Y; Perussia B; Campbell KS
    J Immunol; 2007 Sep; 179(5):2766-73. PubMed ID: 17709490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor.
    Monneret G; Gravel S; Diamond M; Rokach J; Powell WS
    Blood; 2001 Sep; 98(6):1942-8. PubMed ID: 11535533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipocalin-type prostaglandin D synthase-derived PGD
    Omori K; Morikawa T; Kunita A; Nakamura T; Aritake K; Urade Y; Fukayama M; Murata T
    J Pathol; 2018 Jan; 244(1):84-96. PubMed ID: 29124765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing immunomodulatory roles of prostaglandin D2 during the progression of skin inflammation.
    Sarashina H; Tsubosaka Y; Omori K; Aritake K; Nakagawa T; Hori M; Hirai H; Nakamura M; Narumiya S; Urade Y; Ozaki H; Murata T
    J Immunol; 2014 Jan; 192(1):459-65. PubMed ID: 24298012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 15R-PGD2: a potential DP2 receptor agonist.
    Kim S; Bellone S; Maxey KM; Powell WS; Lee GJ; Rokach J
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1873-6. PubMed ID: 15780624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGD2 DP1 receptor stimulation following stroke ameliorates cerebral blood flow and outcomes.
    Ahmad AS
    Neuroscience; 2014 Oct; 279():260-8. PubMed ID: 25218962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRTH2 is not involved in the anti-enteropooling effect of PGD2 in the small intestine.
    Prenn C; Heinemann A; Schuligoi R; Peskar BA
    Pharmacology; 2008; 81(3):236-40. PubMed ID: 18212515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells.
    Sedej M; Schröder R; Bell K; Platzer W; Vukoja A; Kostenis E; Heinemann A; Waldhoer M
    J Allergy Clin Immunol; 2012 Feb; 129(2):492-500, 500.e1-9. PubMed ID: 21930295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells.
    Xue L; Gyles SL; Wettey FR; Gazi L; Townsend E; Hunter MG; Pettipher R
    J Immunol; 2005 Nov; 175(10):6531-6. PubMed ID: 16272307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice.
    van den Brule S; Wallemme L; Uwambayinema F; Huaux F; Lison D
    J Pharmacol Exp Ther; 2010 Nov; 335(2):472-9. PubMed ID: 20719937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.